NKO Partners has advised Dr Max on its acquisition of Zalfija.
Zalfija is a pharmacy institution based in Svrljig, Serbia, comprising 30 retail units across various towns in the country.
Earlier in 2025, NKO Partners advised Dr Max on its acquisition of VIVA Pharm (as reported by CEE Legal Matters on January 15, 2025).
In 2024, NKO Partners advised Dr Max on the acquisitions of the Ivancic i Sin Pharmacy Chain in Serbia (as reported by CEE Legal Matters on December 10, 2024), the Miletic Plus pharmacy chain (as reported by CEE Legal Matters on May 21, 2024), and Pet-Sar Farm (as reported by CEE Legal Matters on February 15, 2024). In 2023, the firm advised Dr Max on the acquisitions of Melem Pharmacy (as reported on December 1, 2023), the Dr Ristic pharmacy chain (as reported on November 9, 2023), the Uniprom pharmacy chain in Zajecar (as reported on October 4, 2023), Nova Pharm (as reported on March 28, 2023), Beolek (as reported on March 9, 2023), Cvejic (as reported on January 31, 2023), as well as AU Medis Lek (as reported by CEE Legal Matters on January 6, 2023). The firm had also advised the Dr Max Group on its acquisition of several other pharmacy chains in Serbia in 2022, including Pancevo-based AU Kod Suncanog Sata and Veliko Gradiste-based AU Selic (as reported on October 11, 2022), Belgrade-based K-Pharma (as reported on June 8, 2022), the Janja pharmacy chain (as reported on March 28, 2022), and the Zlatni Lav pharmacies (as reported on January 5, 2022).
The NKO Partners team included Partners Djordje Nikolic and Branko Jankovic and Associate Kristina Stosic.
